首页> 外文期刊>Patient Safety in Surgery >Preoperative Glucagon-like peptide-1 receptor imaging reduces surgical trauma and pancreatic tissue loss in insulinoma patients: a report of three cases
【24h】

Preoperative Glucagon-like peptide-1 receptor imaging reduces surgical trauma and pancreatic tissue loss in insulinoma patients: a report of three cases

机译:术前胰高血糖素样肽-1受体显像减少胰岛素瘤患者的手术创伤和胰腺组织损失:三例报告

获取原文
           

摘要

Background Insulinomas are rare tumors, in the majority of cases best treated by surgical resection. Preoperative localization of insulinoma is challenging. The more precise the preoperative localization the less invasive and safer is the resection. The purpose of the study is to check the impact of a new technique to localize insulinoma on the surgical strategy. Findings We present exact preoperative localization with Glucagon-like peptide-1 receptor (GLP-1R) imaging. This allows a more precise resection thereby reducing surgical access trauma, loss of healthy pancreatic tissue and increasing safety and quality of the surgical intervention. Conclusion With the help of precise preoperative localization of insulinoma with GLP-1R imaging the surgeon is able to minimize the amount of resected healthy pancreatic tissue. We hypothesize that GLP-1R imaging will become a preoperative diagnostic tool to be used for many patients scheduled for open or laparoscopic insulinoma resection.
机译:背景胰岛素瘤是罕见的肿瘤,在大多数情况下,最好通过手术切除来治疗。胰岛素瘤的术前定位具有挑战性。术前定位越精确,切除的侵入性和安全性就越低。这项研究的目的是检查一种定位胰岛素瘤的新技术对手术策略的影响。研究结果我们提供了胰高血糖素样肽1受体(GLP-1R)成像的确切术前定位。这允许更精确的切除,从而减少外科手术创伤,健康的胰腺组织的损失并提高外科手术的安全性和质量。结论借助GLP-1R成像在胰岛素瘤的术前精确定位的帮助下,外科医生能够最大程度地减少健康胰腺组织的切除量。我们假设GLP-1R成像将成为许多计划进行开放式或腹腔镜胰岛素瘤切除术的患者使用的术前诊断工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号